In Brief: SmithKline Beecham's Relafen
Executive Summary
SmithKline Beecham's Relafen: Nabumetone nonsteroidal anti-inflammatory drug product accounts for one-fifth of dollar volume in the U.S. branded NSAID market. The Oct. 30 issue of "The Pink Sheet" (p. 21) incorrectly reported Relafen's ranking...